Tracking the KNSA option chain helps you see every strike and expiry on Kiniksa Pharmaceuticals International Plc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Kiniksa Pharmaceuticals International Plc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of KNSA options activity at a glance. Use our scanner to monitor the KNSA option chain in real time and filter for the KNSA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For KNSA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the KNSA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where KNSA stock options are being actively traded and where they are not.
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response.
Kiniksa Pharmaceuticals, Ltd. was incorporated in 2015 and is based in Hamilton, Bermuda.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Kiniksa Pharmaceuticals International Plc's full chain across every expiry, highlights the most liquid strikes, and lets you screen KNSA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of KNSA stock options — let the full option chain come to you, pre-filtered and ready to trade.
